Matches in SemOpenAlex for { <https://semopenalex.org/work/W2092171503> ?p ?o ?g. }
Showing items 1 to 75 of
75
with 100 items per page.
- W2092171503 endingPage "129" @default.
- W2092171503 startingPage "127" @default.
- W2092171503 abstract "The aim of this study was to determine a possible association between recidivist superficial thrombophlebitis and anticardiolipin antibodies. Forty-five patients with two or more episodes of superficial thrombophlebitis in lower limbs (33 women and 12 men with ages ranging from 17 to 60 years, average: 39.8) were studied. The control group was formed by 100 voluntary donors from the blood bank (83 men and 17 women, age range: 21 to 59 years, average: 35.4). Anticardiolipin antibody concentrations were determined by enzyme-linked immunosorbent assay (ELISA). For semiquantitative detection in human sera with use of QUANTA Lite ACA IgG/IgM--INOVA Diagnostic, Inc., and positive values were considered as 15 GPL units/mL and 12.5 MPL units/mL for immunoglobulin G (IgG) and IgM, respectively, as recommended by the test. The Odds Ratio method was chosen for statistical analysis with a confidence interval (CI) of 95%. In 15 patients (33.3%) anticardiolipin antibody positivity was detected, whereas in 12 patients (26.7%) it occurred as immunoglobulin M (IgM) anticardiolipin and in 3 (6.7%) as immunoglobulin G anticardiolipin. In the control group, positivity was found in 7 patients (7%) for those antibodies. Furthermore, the Odds Ratio = 6.64 with CI = 95% and values ranging from 2.48 to 17.82 (p < 0.05) were significant, as well as for IgM/IgG anticardiolipin proportion with Odds Ratio = 5.09, C = 95% and values varying from 1.33 to 19.54 (p < 0.05). The authors conclude that there is a correlation between the presence of anticardiolipin antibodies and recurrent superficial thrombophlebitis." @default.
- W2092171503 created "2016-06-24" @default.
- W2092171503 creator A5043740490 @default.
- W2092171503 creator A5054691814 @default.
- W2092171503 creator A5080990130 @default.
- W2092171503 date "2001-02-01" @default.
- W2092171503 modified "2023-09-26" @default.
- W2092171503 title "Superficial Thrombophlebitis and Anticardiolipin Antibodies" @default.
- W2092171503 cites W2109451688 @default.
- W2092171503 cites W2327141264 @default.
- W2092171503 doi "https://doi.org/10.1177/000331970105200206" @default.
- W2092171503 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11228085" @default.
- W2092171503 hasPublicationYear "2001" @default.
- W2092171503 type Work @default.
- W2092171503 sameAs 2092171503 @default.
- W2092171503 citedByCount "32" @default.
- W2092171503 countsByYear W20921715032012 @default.
- W2092171503 countsByYear W20921715032013 @default.
- W2092171503 countsByYear W20921715032014 @default.
- W2092171503 countsByYear W20921715032016 @default.
- W2092171503 countsByYear W20921715032017 @default.
- W2092171503 countsByYear W20921715032019 @default.
- W2092171503 countsByYear W20921715032021 @default.
- W2092171503 crossrefType "journal-article" @default.
- W2092171503 hasAuthorship W2092171503A5043740490 @default.
- W2092171503 hasAuthorship W2092171503A5054691814 @default.
- W2092171503 hasAuthorship W2092171503A5080990130 @default.
- W2092171503 hasConcept C126322002 @default.
- W2092171503 hasConcept C156957248 @default.
- W2092171503 hasConcept C159654299 @default.
- W2092171503 hasConcept C203014093 @default.
- W2092171503 hasConcept C2776149422 @default.
- W2092171503 hasConcept C2779324797 @default.
- W2092171503 hasConcept C2780868729 @default.
- W2092171503 hasConcept C2780898057 @default.
- W2092171503 hasConcept C3018762881 @default.
- W2092171503 hasConcept C44249647 @default.
- W2092171503 hasConcept C65409693 @default.
- W2092171503 hasConcept C71924100 @default.
- W2092171503 hasConcept C90924648 @default.
- W2092171503 hasConceptScore W2092171503C126322002 @default.
- W2092171503 hasConceptScore W2092171503C156957248 @default.
- W2092171503 hasConceptScore W2092171503C159654299 @default.
- W2092171503 hasConceptScore W2092171503C203014093 @default.
- W2092171503 hasConceptScore W2092171503C2776149422 @default.
- W2092171503 hasConceptScore W2092171503C2779324797 @default.
- W2092171503 hasConceptScore W2092171503C2780868729 @default.
- W2092171503 hasConceptScore W2092171503C2780898057 @default.
- W2092171503 hasConceptScore W2092171503C3018762881 @default.
- W2092171503 hasConceptScore W2092171503C44249647 @default.
- W2092171503 hasConceptScore W2092171503C65409693 @default.
- W2092171503 hasConceptScore W2092171503C71924100 @default.
- W2092171503 hasConceptScore W2092171503C90924648 @default.
- W2092171503 hasIssue "2" @default.
- W2092171503 hasLocation W20921715031 @default.
- W2092171503 hasLocation W20921715032 @default.
- W2092171503 hasOpenAccess W2092171503 @default.
- W2092171503 hasPrimaryLocation W20921715031 @default.
- W2092171503 hasRelatedWork W2006980689 @default.
- W2092171503 hasRelatedWork W2009355345 @default.
- W2092171503 hasRelatedWork W2092171503 @default.
- W2092171503 hasRelatedWork W2099244599 @default.
- W2092171503 hasRelatedWork W2102440256 @default.
- W2092171503 hasRelatedWork W2322622709 @default.
- W2092171503 hasRelatedWork W2397569663 @default.
- W2092171503 hasRelatedWork W2775556957 @default.
- W2092171503 hasRelatedWork W4233016836 @default.
- W2092171503 hasRelatedWork W2274893685 @default.
- W2092171503 hasVolume "52" @default.
- W2092171503 isParatext "false" @default.
- W2092171503 isRetracted "false" @default.
- W2092171503 magId "2092171503" @default.
- W2092171503 workType "article" @default.